Skip to main content

Three ETFs Up 100% (And More) In 2012

By: ETFdb
With two thirds of 2012 in the books, the year is on track to be a relatively solid stretch for most investors. Despite an abundance of potential land mines and significant challenges, such as stubbornly high unemployment, general uncertainty over the future of the Euro zone, and a “fiscal cliff” on the horizon, stocks have generally continued their upward climb that began when markets bottomed out about three and a half years ago. Broad-based stock ETFs like the S&P 500 SPDR (SPY) are firmly in positive territory for the year, while the tech-heavy PowerShares QQQ has posted even more impressive gains thanks to a red hot tech sector. Certain corners of the market have been quietly posting some impressive performances; some homebuilder ETFs have gained close to 50%, while many biotech ETFs have added 30% or more [see the 100 best and 100 worst ETF performers of 2012]. But the biggest [...] Click here to read the original article on ETFdb.com. Related Posts: 101 ETF Lessons Every Financial Advisor Should Learn August ETF Stats: Keeping The Winning Streak Alive (Just Barely) ETF Tools Every Investor Needs 10 Surprising ETF Stats From Mid Year ETF Data The Most Successful ETFs Of All-Time
With two thirds of 2012 in the books, the year is on track to be a relatively solid stretch for most investors. Despite an abundance of potential land mines and significant challenges, such as stubbornly high unemployment, general uncertainty over the future of the Euro zone, and a “fiscal cliff” on the horizon, stocks have generally continued their upward climb that began when markets bottomed out about three and a half years ago. Broad-based stock ETFs like the S&P 500 SPDR (SPY) are firmly in positive territory for the year, while the tech-heavy PowerShares QQQ has posted even more impressive gains thanks to a red hot tech sector. Certain corners of the market have been quietly posting some impressive performances; some homebuilder ETFs have gained close to 50%, while many biotech ETFs have added 30% or more [see the 100 best and 100 worst ETF performers of 2012]. But the biggest [...]

Click here to read the original article on ETFdb.com.

Related Posts:

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.